Smith & Nephew PLC
- BID
13.3
- ASK
13.4
- 1,243 Units1,230 Units
- 07/21, 20:01:20 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
5.26%
Market Cap
11.30 Bil.
P/E Ratio
22.64
Dividend Yield
2.34 %
Earnings per Share
0.64 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 13.3 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 08:01:20 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 13.5 | 13.2 |
| PREV. DAY'S PRICE | 13.4 | (07/20) |
| CHANGE DAY BEFORE | -0.10 | -0.75 % |
| 52 WEEK HIGH / LOW | 16.54 (09/10) | 12.3 (05/12) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.28 | 0.44 | 0.64 | 0.96 | 1.07 |
DIVIDENDS PER SHARE | 0.35 | 0.34 | 0.34 | 0.36 | 0.40 |
DIVIDEND YIELD IN % | 2.82 % | 2.92 % | 2.34 % | - | - |
DIVIDEND GROWTH IN % | -5.08 % | -2.21 % | -0.96 % | - | - |
PRICE - EARNINGS RATIO | 44.40 | 26.85 | 22.64 | 14.02 | 12.60 |
PRICE - BOOK RATIO | 2.30 | 2.06 | 2.68 | - | - |
PRICE - SALES RATIO | 2.11 | 1.91 | 2.31 | - | - |
PRICE - CASH FLOW RATIO | 19.25 | 11.24 | 11.09 | - | - |
Master Data
| WKN | 502816 |
| ISIN | GB0009223206 |
| SYMBOL | NPW1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Smith & Nephew |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | British Pound Sterling |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 842.02 Mil. |
| MARKET CAPITALISATION | 11.30 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -2.90 % | 2.29 % | -7.59 % | -2.19 % | 5.26 % | -1.18 % | -21.45 % | -4.80 % |
| HIGH | 13.90 | 13.90 | 14.50 | 15.95 | 16.54 | 16.54 | 18.27 | 15.95 |
| LOW | 13.00 | 12.50 | 12.30 | 12.30 | 12.30 | 10.05 | 10.05 | 12.30 |
Dividende
pro Aktie
Company profile
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Structured products for Smith & Nephew PLC
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.